Search
Search Results
-
A review of biosensors for the detection of B-type natriuretic peptide as an important cardiovascular biomarker
Heart disease, as the most serious threat to human health globally, is responsible for rising mortality rates, largely due to lifestyle and diet....
-
-
Sleep-disordered breathing is independently associated with elevated natriuretic peptide levels in patients with cardiovascular diseases
Sleep disorders and sleep duration have attracted considerable attention as potential modifiable risk factors for the development and progression of...
-
Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure
Thyroid hormone metabolism can be closely associated with cardiovascular disorders. We examined the relationship between low triiodothyronine (T3)...
-
Angiotensin Receptor–Neprilysin Inhibitors and the Natriuretic Peptide Axis
Purpose of the ReviewThe purpose of this review is to describe the effects of angiotensin receptor neprilysin inhibitor (ARNI) therapy on the...
-
N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
Coronary artery lesion (CAL) caused by Kawasaki disease (KD) is currently the most common acquired heart disease in children in many countries....
-
Peptide Composition and Identification of a Peptide with Anti-Inflammatory and Antiplatelet Properties in Cattle Prostate Extract
An attempt to identify the peptide structure of bovine prostate extract using water/vinegar technology followed by tangential ultrafiltration is...
-
Electrochemiluminescence immunoassay for the N-terminal pro-B-type natriuretic peptide based on resonance energy transfer between a self-enhanced luminophore composed of silver nanocubes on gold nanoparticles and a metal-organic framework of type MIL-125
The N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a marker of heart failure. A novel sandwich type electrochemiluminescence (ECL)...
-
Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
Heart failure is a significant public health concern characterized by notable rates of morbidity and mortality. Despite the presence of...
-
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy
Heart failure (HF) is a progressive condition with a clinical picture resulting from reduced cardiac output (CO) and/or elevated left ventricular...
-
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium
Quadruple therapy is effective for patients with heart failure with reduced ejection fraction, providing significant clinical benefits, including...
-
Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension
The aim of the study was to evaluate the levels of cardiac biomarkers endothelin 1, B-natriuretic peptide (BNP), N-terminal pro-B-type natriuretic...
-
Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is one of the most common diseases, that managed by several medications such as Glimepiride and Dapagliflozin. This...
-
Identification and characterization of critical values in therapeutic drug monitoring: a retrospective analysis
Therapeutic drug monitoring (TDM) is a crucial clinical practice that improves pharmacological effectiveness and prevent severe drug-related adverse...
-
Global longitudinal strain and plasma biomarkers for prognosis in heart failure complicated by diabetes: a prospective observational study
BackgroundHeart failure (HF) and diabetes are associated with increased incidence and worse prognosis of each other. The prognostic value of global...
-
Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial
Doxorubicin (DOX) causes deleterious cardiotoxicity. We aimed to investigate the protective roles of metformin and donepezil against DOX-induced...
-
Elevated urinary angiotensinogen excretion links central and renal hemodynamic alterations
Inappropriate activation of intrarenal renin–angiotensin system (RAS) may contribute to the pathogenesis of cardio-renal syndrome (CRS). We aimed to...
-
Causal associations between cardiorespiratory fitness and type 2 diabetes
Higher cardiorespiratory fitness is associated with lower risk of type 2 diabetes. However, the causality of this relationship and the biological...
-
The efficacy and safety of sacubitril/valsartan in heart failure with reduced ejection fraction patients with hypotension
Despite previous studies showing that patients with low systolic blood pressure (sBP) in heart failure with reduced ejection fraction (HFrEF) has a...
-
Looking into the Kinetics of NT-proBNP and sST2 Changes in Patients with Heart Failure Treated with Sacubitril/Valsartan: A Hint to Different Therapeutic Pathways
Background and objectiveN-terminal pro-B-type natriuretic peptide (NT-proBNP) and soluble interleukin 1 receptor-like 1 ST2 (sST2) are biomarkers...
